Melissa Lumish, MD – Hematology and Oncology [Video]

To schedule an appointment with hematologist and oncologist, Dr. Melissa Lumish, click here: https://bit.ly/DrMelissaLumish

Expertise

Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Gastrointestinal Cancers
Immunotherapy

Melissa Lumish, MD, is a medical oncologist at University Hospitals Seidman Cancer Center with expertise in gastrointestinal cancers. Her specific areas of interest are early onset gastrointestinal cancers (young adults under the age of 50), the use of immunotherapy and the role of the microbiome in cancer growth and treatment.

Before she was recruited to join University Hospitals, Dr. Lumish was a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City. Dr. Lumish earned her undergraduate degree from Cornell University and her medical degree from New York University School of Medicine. She completed an internal medicine residency at Massachusetts General Hospital/Harvard Medical School in Boston, Massachusetts and a fellowship in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center.

Dr. Lumish’s research has been published in the New England Journal of Medicine, Journal of Clinical Oncology, JAMA Oncology, Journal for ImmunoTherapy of Cancer, American Journal of Surgery, Journal of Surgical Oncology and Scientific Reports. She was one of the researchers involved in a small but groundbreaking clinical trial published in the New England Journal of Medicine which showed that patients with mismatch repair deficient locally advanced rectal cancer can achieve a complete clinical response with 6 months of treatment with an immune checkpoint inhibitor (dostarlimab) without radiation, surgery or chemotherapy.

Among other honors and awards, Dr. Lumish is the recipient of the American Association for Cancer Research 2021 Doreen J. Putrah Cancer Research Foundation Scholar-in-Training Award, 2021; Annual Meeting Merit Award, American Society of Clinical Oncology, 2021; Donald L. Morton Award, 9th Annual, Journal of Surgical Oncology, 2022; and Conquer Cancer Young Investigator Award, American Society of Clinical Oncology, Conquer Cancer, 2022.

University Hospitals is one of the nation’s leading health care systems, providing patient-centered care that meets the highest standards for quality and patient safety and have received numerous awards and recognitions from some of the most prestigious institutions in the country for our leadership and exceptional patient outcomes. As an accountable care organization, we foster long-term patient-provider relationships that help promote preventive care, increase wellness and healthy behaviors, decrease emergency episodes, and prevent hospitalizations. To learn more: https://www.uhhospitals.org